Coldstream Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $40.6M | Buy |
44,190
+619
| +1% | +$628K | 0.5% | 38 |
|
|
2025
Q4 | $46.8M | Buy |
43,571
+1,153
| +3% | +$1.1M | 0.6% | 34 |
|
|
2025
Q3 | $32.4M | Buy |
42,418
+8,659
| +26% | +$6.44M | 0.44% | 40 |
|
|
2025
Q2 | $26.3M | Buy |
33,759
+10,230
| +43% | +$7.95M | 0.43% | 41 |
|
|
2025
Q1 | $19.4M | Buy |
23,529
+277
| +1% | +$230K | 0.41% | 39 |
|
|
2024
Q4 | $18M | Buy |
23,252
+63
| +0.3% | +$52.2K | 0.38% | 41 |
|
|
2024
Q3 | $20.5M | Sell |
23,189
-543
| -2% | -$488K | 0.44% | 31 |
|
|
2024
Q2 | $21.5M | Sell |
23,732
-38
| -0.2% | -$30.4K | 0.52% | 26 |
|
|
2024
Q1 | $18.5M | Buy |
23,770
+225
| +1% | +$160K | 0.47% | 32 |
|
|
2023
Q4 | $13.7M | Buy |
23,545
+94
| +0.4% | +$54.9K | 0.38% | 40 |
|
|
2023
Q3 | $12.6M | Buy |
23,451
+8,279
| +55% | +$4.27M | 0.41% | 36 |
|
|
2023
Q2 | $7.12M | Buy |
15,172
+326
| +2% | +$137K | 0.23% | 65 |
|
|
2023
Q1 | $5.1M | Buy |
14,846
+247
| +2% | +$83.3K | 0.17% | 93 |
|
|
2022
Q4 | $5.34M | Buy |
+14,599
| New | +$5.18M | 0.2% | 87 |
|
|
2022
Q2 | $4.58M | Buy |
14,117
+1,895
| +16% | +$569K | 0.18% | 94 |
|
|
2022
Q1 | $3.5M | Sell |
12,222
-1,159
| -9% | -$298K | 0.12% | 109 |
|
|
2021
Q4 | $3.7M | Buy |
13,381
+5,477
| +69% | +$1.39M | 0.12% | 114 |
|
|
2021
Q3 | $1.17M | Sell |
7,904
-154
| -2% | -$38K | 0.06% | 159 |
|
|
2021
Q2 | $1.85M | Buy |
8,058
+90
| +1% | +$18.1K | 0.07% | 182 |
|
|
2021
Q1 | $1.49M | Sell |
7,968
-74
| -0.9% | -$14.5K | 0.09% | 122 |
|
|
2020
Q4 | $1.36M | Buy |
8,042
+721
| +10% | +$108K | 0.08% | 122 |
|
|
2020
Q3 | $1.08M | Sell |
7,321
-276
| -4% | -$42.7K | 0.09% | 120 |
|
|
2020
Q2 | $1.25M | Buy |
7,597
+2,608
| +52% | +$400K | 0.11% | 104 |
|
|
2020
Q1 | $692K | Buy |
4,989
+377
| +8% | +$51.8K | 0.08% | 140 |
|
|
2019
Q4 | $606K | Sell |
4,612
-44
| -0.9% | -$5.1K | 0.05% | 185 |
|
|
2019
Q3 | $521K | Sell |
4,656
-288
| -6% | -$32.1K | 0.04% | 193 |
|
|
2019
Q2 | $548K | Sell |
4,944
-133
| -3% | -$15.7K | 0.05% | 192 |
|
|
2019
Q1 | $659K | Sell |
5,077
-170
| -3% | -$20.7K | 0.06% | 180 |
|
|
2018
Q4 | $607K | Buy |
5,247
+1,165
| +29% | +$130K | 0.06% | 183 |
|
|
2018
Q3 | $438K | Buy |
4,082
+311
| +8% | +$31.1K | 0.04% | 218 |
|
|
2018
Q2 | $322K | Buy |
3,771
+795
| +27% | +$65.3K | 0.03% | 244 |
|
|
2018
Q1 | $230K | Sell |
2,976
-461
| -13% | -$37.1K | 0.02% | 267 |
|
|
2017
Q4 | $290K | Buy |
3,437
+655
| +24% | +$55.7K | 0.03% | 245 |
|
|
2017
Q3 | $238K | Sell |
2,782
-145
| -5% | -$11.9K | 0.03% | 266 |
|
|
2017
Q2 | $241K | Buy |
2,927
+555
| +23% | +$45.3K | 0.03% | 241 |
|
|
2017
Q1 | $200K | Buy |
+2,372
| New | +$190K | 0.03% | 247 |
|
Other funds holding LLY
VCM
VPM
Coldstream Capital Management's LLY Position: Q1 2026 in Review
Coldstream Capital Management increased its Eli Lilly (LLY) stake by 1.4% in Q1 2026, buying an estimated $628K and bringing the position to 44,190 shares worth $40.6M. The position accounts for 0.5% of the portfolio, ranked #38.
Coldstream Capital Management first reported a position in LLY in Q1 2017 and has held it in 36 quarters since. The position peaked at $46.8M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Coldstream Capital Management held 44,190 shares of Eli Lilly worth $40.6M as of Q1 2026.
- Coldstream Capital Management bought 619 Eli Lilly shares in Q1 2026, an estimated $628K.
- Eli Lilly made up 0.5% of Coldstream Capital Management's portfolio in Q1 2026, its #38 holding.
- Coldstream Capital Management first reported a position in Eli Lilly in Q1 2017 and has held it in 36 quarters since.
- Coldstream Capital Management's Eli Lilly position peaked at $46.8M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Coldstream Capital Management's 13F filing for Q1 2026, filed 8 May 2026.